Last reviewed · How we verify
NCT05645809
Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery
NA trial testing MONOFIX® PGCL in Laparoscopic Hysterectomy in 98 participants. Status unknown.
31 March 2023
Quick facts
| Lead sponsor | Samyang Biopharmaceuticals Corporation |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 98 |
| Start date | 3 November 2022 |
| Primary completion | 31 March 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- MONOFIX® PGCL
- Quill Monoderm™
Conditions studied
- Laparoscopic Hysterectomy — all drugs for Laparoscopic Hysterectomy →
Sponsor
Samyang Biopharmaceuticals Corporation — full company profile →
Who can join
19 and older, female only, with Laparoscopic Hysterectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture Compared to Quill MonodermTM Suture in Laparoscopic Surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05645809
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Laparoscopic Hysterectomy
Currently open trials in the same condition.
- NCT07232108 — Intrathecal Morphine Versus Trocar-Site and Intraperitoneal Bupivacaine for Quality of Recovery After Laparoscopic Hyste · NA · recruiting
- NCT07232446 — Effect of Vulvar Re-Antisepsis Before Cystoscopy on Urinary Infections in Laparoscopic Hysterectomy · active not recruiting
- NCT07226375 — Endoscopic Tissue Cutting and Abdominal Extraction Device vs. Conventional Cold Scalpel · NA · recruiting
- NCT07101250 — Preoperative Acetazolamide · Phase 4 · recruiting
- NCT07062367 — Sevoflurane With or Without Intravenous Lidocaine Infusion Versus Propofol Anesthesia on Intracranial Pressure and Cereb · NA · recruiting
Other Samyang Biopharmaceuticals Corporation trials
Trials by the same sponsor.
- NCT07467239 — A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds · NA · recruiting
- NCT06961448 — A Study in Adults Evaluating Polycaprolactone Microsphere Filler for Treatment of Moderate to Severe Nasolabial Folds · NA · not yet recruiting
- NCT06402058 — A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement · NA · not yet recruiting
- NCT06295172 — A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement · NA · not yet recruiting
- NCT06093321 — A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05645809 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samyang Biopharmaceuticals Corporation
- Last refreshed: 12 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05645809.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing